Evidence map›Paper›PMID 17389239›Full record

ArticleThe Journal of experimental medicine2007

The Niemann-Pick type C2 protein loads isoglobotrihexosylceramide onto CD1d molecules and contributes to the thymic selection of NKT cells.

Nicolas Schrantz, Yuval Sagiv, Yang Liu, Paul B Savage, Albert Bendelac, Luc Teyton

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of experimental medicine, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed
4.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 100 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. The Effect of Lipid Metabolism on CD4Mediators of inflammation · 2021
    Review
  10. Understanding and Treating Niemann-Pick Type C Disease: Models Matter.International journal of molecular sciences · 2020
    Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. Review
  16. Article
  17. Natural killer T cells in atherosclerosis.Nature reviews. Cardiology · 2017
    Review
  18. From Lysosomal Storage Diseases to NKT Cell Activation and Back.International journal of molecular sciences · 2017
    Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Nicolas SchrantzDepartment of Immunology, The Scripps Research Institute, La Jolla, CA 92037, USA.
Yuval Sagiv
Yang Liu
Paul B Savage
Albert Bendelac
Luc Teyton
Brigham Young University · USScripps Research Institute · USUniversity of Chicago · US

Funding

Th1/Th2 Glycolipid AdjuvantsP01AI053725 · NIAID · UNIVERSITY OF CHICAGO · PI TEYTON, LUC · 2003 to 2012
$11.8M
Transcriptional Regulation of Innate-Like T CellsR01AI038339 · NIAID · UNIVERSITY OF CHICAGO · PI ESTERHAZY, DARIA · 1996 to 2025
$7.6M
Transcriptional Regulation of Innate-Like T CellsR37AI038339 · NIAID · UNIVERSITY OF CHICAGO · PI BENDELAC, ALBERT S. · 2017 to 2023
$3.4M
CLASS I DOWN-REGULATION OF GUINEA PIG CYTOMEGALOVIRUSF31AI010537 · NIAID · VIRGINIA COMMONWEALTH UNIVERSITY · PI LACAYO, JUAN C · 2000 to 2002
$75k
NIAID NIH HHS AI038339NIAID NIH HHS P01 AI053725NIAID NIH HHS P01AI1053725NIAID NIH HHS R01 AI038339NIAID NIH HHS R37 AI038339
6 · The paper itself

Abstract

The Niemann-Pick type C2 (NPC2) protein is a small, soluble, lysosomal protein important for cholesterol and sphingolipid transport in the lysosome. The immunological phenotype of NPC2-deficient mice was limited to an impaired thymic selection of Valpha14 natural killer T cells (NKT cells) and a subsequent reduction of NKT cells in the periphery. The remaining NKT cells failed to produce measurable quantities of interferon-gamma in vivo and in vitro after activation with alpha-galactosylceramide. In addition, thymocytes and splenocytes from NPC2-deficient mice were poor presenters of endogenous and exogenous lipids to CD1d-restricted Valpha14 hybridoma cells. Importantly, we determined that similar to saposins, recombinant NPC2 was able to unload lipids from and load lipids into CD1d. This transfer activity was associated with a dimeric form of NPC2, suggesting a unique mechanism of glycosphingolipid transfer by NPC2. Similar to saposin B, NPC2 dimers were able to load isoglobotrihexosylceramide (iGb3), the natural selecting ligand of NKT cells in the thymus, into CD1d. These observations strongly suggested that the phenotype observed in NPC2-deficient animals was directly linked to the efficiency of the loading of iGb3 into CD1d molecules expressed by thymocytes. This conclusion was supported by the rescue of endogenous and exogenous iGb3 presentation by recombinant NPC2. Thus, the loading of endogenous and exogenous lipids and glycolipids onto CD1d is dependent on various small, soluble lipid transfer proteins present in the lysosome.

Indexed as

AnimalsAntigens, CD1Biological TransportCells, CulturedGlobosidesGlycosphingolipidsLigandsMiceMice, KnockoutReceptors, Antigen, T-Cell, alpha-betaSpleenThymus GlandT-Lymphocytes, RegulatoryVesicular Transport ProteinsAntigens, CD1GlobosidesGlycosphingolipidsisoglobotriaosylceramideLigandsNpc2 protein, mouseReceptors, Antigen, T-Cell, alpha-betaVesicular Transport Proteins

Identifiers

PMID17389239
PMCPMC2118543
OpenAlexW2150105360

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.